Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716918 | PMC |
| http://dx.doi.org/10.1164/rccm.202205-0835LE | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to the Letter to the Editor regarding 'PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?' by T. Nishimura and H. Fujimoto.
Ann Oncol
November 2024
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Reply to a letter.
J Anesth
November 2024
Department of Anesthesiology, Kobe University Hospital, Kobe, Japan.
Reply to Albulushi-Frailty Index as a Potential Assessment Tool for Multidomain Frailty in Heart Failure.
Can J Cardiol
September 2024
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Reply.
Ophthalmol Retina
June 2024
University of Hawai'i at Mānoa John A Burns School of Medicine, Aiea, Hawaii.
Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
Breast Cancer
May 2024
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!